サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375112

北米の医療用マリファナ市場の2028年予測-地域別分析：製品タイプ、用途、流通チャネル別

North America Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and Distribution Channel
出版日: | 発行: The Insight Partners | ページ情報: 英文 127 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
北米の医療用マリファナ市場の2028年予測-地域別分析：製品タイプ、用途、流通チャネル別
出版日: 2023年08月22日
発行: The Insight Partners
ページ情報: 英文 127 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の医療用マリファナ市場は、2022年の71億7,017万米ドルから2028年には207億6,041万米ドルに成長すると予測されています。2022年から2028年までのCAGRは19.4%と推定されます。

医療用マリファナ製品の承認が北米医療用マリファナ市場の成長を後押し

大麻の薬効が期待できることから、さまざまな研究者や企業が大麻を医療用途に使用することに関心を寄せています。例えば、テトラヒドロカンナビノール（THC）は主に医薬品製造に使用されています。米国食品医薬品局（FDA）は、ナボリンを有効成分とするセサメットのようなTHCベースの医薬品を承認しているが、これはTHCのような構造を持つ合成由来製品です。セサメットは化学療法を受けている患者の吐き気の治療に処方されます。セサメットは一般に、他の薬では吐き気や嘔吐をコントロールできない場合に処方されます。FDAは米国でマリノールとシンドロスも治療薬として承認しています。マリノールとシンドロスには有効成分ドロナビノール-大麻の精神作用成分とされる合成9-THC-が含まれています。マリノールとシンドロスは、AIDSの適応症の一つとして開発された消耗性症候群の患者の食欲を刺激するために処方されています。同様に、さまざまな大麻ベースの製品が承認されているか、臨床試験中です。例えば、ナビキシモルス（サティベックス）はカナダで商品化された承認薬です。ナビキシモルスは、多発性硬化症に関連する痙縮や神経障害性疼痛の治療に用いられる大麻エキスです。THCとその他のカンナビジオール（CBD）が配合されています。2020年2月、カナダのCanaQuest Medical Corp社は、カナダ保健省にメンタビノールの製造と商業化の承認を申請しました。メンタビノールはTHCを主成分とする製品で、大麻法に基づき承認申請を行っています。FDAによる上記のマリファナベースの製品の承認が増加していることが、医療用マリファナ市場を牽引しています。

北米医療用マリファナ市場概要

北米の医療用マリファナ市場は、米国、カナダ、メキシコに区分されます。医療用マリファナ市場は米国が最大のシェアを占めると推定されます。医療用マリファナ市場の成長の背景には、革新的な治療用途を模索するための調査や共同研究の増加、医療用マリファナに関する認知度の向上、同地域における主要プレイヤーの存在などがあります。加えて、同地域全体で高齢化人口が増加していることも、同市場の成長を後押しすると思われます。

北米の医療用マリファナ市場の収益と2028年までの予測（金額）

北米医療用マリファナ市場のセグメンテーション

北米の医療用マリファナ市場は、製品タイプ、用途、流通チャネル、国に区分されます。

製品タイプに基づき、北米の医療用マリファナ市場は乾燥形態とエキス形態に区分されます。2022年の北米医療用マリファナ市場では、エキス剤が大きなシェアを占めています。

用途別では、北米の医療用マリファナ市場は疼痛管理、トゥレット病、アルツハイマー病、片頭痛、うつ病と不安、多発性硬化症、がん、その他に区分されます。2022年の北米医療用マリファナ市場では、疼痛管理分野が最大のシェアを占めています。

流通チャネルに基づき、北米の医療用マリファナ市場は小売薬局、eコマース、その他に区分されます。小売薬局セグメントが2022年の北米医療用マリファナ市場で最大のシェアを占めました。

国別では、北米医療用マリファナ市場は米国、カナダ、メキシコに区分されます。2022年の北米医療用マリファナ市場は米国が支配的でした。

Aphria, Inc.、CanaQuest Medical Corporation、Canopy Growth Corporation、Emerald Health Therapeutics Inc.、GW Pharmaceuticals、MARICANN INC.、Organigram Holdings Inc.、Panaxia Pharmaceutical Industries Ltd.、Phoena Holdings Inc.、VIVO Cannabis Inc.が北米医療用マリファナ市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 北米医療用マリファナ市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の医療用マリファナ市場-市場情勢

  • 北米-PEST分析
  • 専門家の見解

第5章 北米医療用マリファナ市場：主要市場力学

  • 市場促進要因
    • 医療用マリファナ製品の承認の増加
    • アメリカにおける医療用大麻の受容の高まり
  • 市場抑制要因
    • ストリートドラッグとしての大麻の違法使用と大麻に関する誤解
  • 市場機会
    • マリファナ産業における雇用機会の増加
  • 今後の動向
    • 医療用マリファナの普及
  • 影響分析

第6章 医療用マリファナ市場-北米分析

  • 北米医療用マリファナ市場の収益と予測分析

第7章 北米医療用マリファナ市場の収益と2028年までの予測-製品別

  • 北米医療用マリファナ市場の製品別売上高シェア（2021年、2028年）
  • 乾燥形態
  • エキス形態

第8章 北米医療用マリファナ市場分析-用途別

  • 北米医療用マリファナ市場の用途別売上高シェア（2021年、2028年）
  • 疼痛管理
  • トゥレット障害
  • アルツハイマー病
  • 偏頭痛
  • うつ病と不安神経症
  • 多発性硬化症
  • がん
  • その他

第9章 北米医療用マリファナ市場：流通チャネル別

  • 北米の医療用マリファナ市場：流通チャネル別（2021年・2028年）
  • 小売薬局
  • eコマース
  • その他

第10章 北米医療用マリファナ市場の収益と2028年までの予測：国別分析

      • 米国
      • カナダ
      • メキシコ

第11章 北米医療用マリファナ市場：業界情勢

  • 北米医療用マリファナ市場の成長戦略（%）
  • オーガニック開発
  • 無機的展開

第12章 企業プロファイル

  • VIVO Cannabis Inc
  • Panaxia Pharmaceutical Industries Ltd.
  • Phoena Holdings Inc.
  • Emerald Health Therapeutics Inc.
  • MARICANN INC.
  • Aphria, Inc.
  • Canopy Growth Corporation
  • CanaQuest Medical Corporation
  • GW Pharmaceuticals
  • Organigram Holdings Inc.

第13章 付録

図表

List Of Tables

  • Table 1. US: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. US: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
  • Table 3. US: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Canada: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Canada: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
  • Table 6. Canada: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Mexico: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Mexico: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
  • Table 9. Mexico: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Organic Developments in the Medical Marijuana Market
  • Table 11. Inorganic Developments in the Medical Marijuana Market
  • Table 12. Glossary of Terms for North America Medical Marijuana Market

List Of Figures

  • Figure 1. North America Medical Marijuana Market Segmentation
  • Figure 2. North America Medical Marijuana Market, By Country
  • Figure 3. North America Medical Marijuana Market Overview
  • Figure 4. Extract Form Held Largest Share of Product Segment in Medical Marijuana Market
  • Figure 5. US to Show Remarkable Growth During Forecast Period
  • Figure 6. North America PEST Analysis
  • Figure 7. North America Medical Marijuana Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 8. North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
  • Figure 9. Dried Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 10. Extract Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
  • Figure 12. Pain Management: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Tourette's: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Alzheimer's Disease: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Migraines: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Depression and Anxiety: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Multiple Sclerosis: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Cancer: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)
  • Figure 21. Retail Pharmacy: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. E-commerce: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. North America Medical Marijuana Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 25. North America Medical Marijuana Market, by Country, 2021 & 2028 (%)
  • Figure 26. US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Growth Strategies in the North America Medical Marijuana Market (%)
目次
Product Code: BMIRE00028793

The North America medical marijuana market is expected to grow from US$ 7,170.17 million in 2022 to US$ 20,760.41 million by 2028. It is estimated to register a CAGR of 19.4% from 2022 to 2028.

Increasing Approvals of Medical Marijuana Products Fuels North America Medical Marijuana Market Growth

The medicinal potential of marijuana has attracted various researchers and companies to use marijuana in medical applications. For instance, tetrahydrocannabinol (THC) is predominantly used for producing medicinal products. The US Food and Drug Administration (FDA) has approved THC-based medicinal products such as Cesamet, which contains naboline as its active ingredient, is a synthetically derived product that has a structure like THC. Cesamet is prescribed for the treatment of nausea in patients receiving chemotherapy. Cesamet is generally prescribed when other medications cannot control nausea and vomiting. The FDA has also approved Marinol and Syndros for therapeutic uses in the US. Marinol and Syndros contain the active ingredient dronabinol-a synthetic 9-THC considered the psychoactive component of cannabis. Marinol and Syndros drugs are prescribed to stimulate appetite in patients with wasting syndrome, developed as one of the indications of AIDS. Similarly, various marijuana-based products have been approved or are in clinical trials. For instance, nabiximols (Sativex) is an approved drug commercialized in Canada. Nabiximols is a cannabis extract used to treat spasticity and neuropathic pain related to multiple sclerosis. It is formulated with a combination of THC and other cannabidiol (CBD). In February 2020, CanaQuest Medical Corp, a Canadian company, applied for the approval of the production and commercialization of Mentabinol to Health Canada. Mentabinol is a THC-based product, and its approval application has been filed under the Cannabis Act. The increase in approval of the above-mentioned marijuana-based products by the FDA is driving the medical marijuana market.

North America Medical Marijuana Market Overview

The North America medical marijuana market is segmented into the US, Canada, and Mexico. The medical marijuana market is estimated to have the largest share in the US. The growth of the medical marijuana market can be attributed to the increasing research and collaborations to explore innovative therapeutic applications, rising awareness regarding medical marijuana, and the presence of key players in the region. In addition, the growing aging population across the region will also favor the growth of the market.

North America Medical Marijuana Market Revenue and Forecast to 2028 (US$ Million)

North America Medical Marijuana Market Segmentation

The North America medical marijuana market is segmented into product type, application, distribution channel, and country.

Based on product type, the North America medical marijuana market is segmented into dried form and extract form. The extract form segment held a larger share of the North America medical marijuana market in 2022.

Based on application, the North America medical marijuana market is segmented into pain management, Tourette's, Alzheimer's disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others. The pain management segment held the largest share of the North America medical marijuana market in 2022.

Based on distribution channel, the North America medical marijuana market is segmented into retail pharmacy, e-commerce, and others. The retail pharmacy segment held the largest share of the North America medical marijuana market in 2022.

Based on country, the North America medical marijuana market is segmented into the US, Canada, and Mexico. The US dominated the North America medical marijuana market in 2022.

Aphria, Inc.; CanaQuest Medical Corporation; Canopy Growth Corporation; Emerald Health Therapeutics Inc.; GW Pharmaceuticals; MARICANN INC.; Organigram Holdings Inc.; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc.; and VIVO Cannabis Inc are the leading companies operating in the North America medical marijuana market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Medical Marijuana Market - by Product
    • 1.3.2 North America Medical Marijuana Market - by Application
    • 1.3.3 North America Medical Marijuana Market - by Distribution Channel
    • 1.3.4 North America Medical Marijuana Market - by Country

2. North America Medical Marijuana Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Medical Marijuana Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America - PEST Analysis
  • 4.3 Expert Opinion

5. North America Medical Marijuana Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Approvals of Medical Marijuana Products
    • 5.1.2 Rising Acceptance of Medicinal Use of Marijuana in America
  • 5.2 Market Restraints
    • 5.2.1 Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana
  • 5.3 Market Opportunities
    • 5.3.1 Increase in Job Opportunities in Marijuana Industry
  • 5.4 Future Trends
    • 5.4.1 Widespread Distribution of Medical Marijuana
  • 5.5 Impact Analysis

6. Medical Marijuana Market - North America Analysis

  • 6.1 North America Medical Marijuana Market Revenue Forecast and Analysis

7. North America Medical Marijuana Market Revenue and Forecast To 2028- by Product

  • 7.1 Overview
  • 7.2 North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
  • 7.3 Dried Form
    • 7.3.1 Overview
    • 7.3.2 Dried Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Extract Form
    • 7.4.1 Overview
    • 7.4.2 Extract Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Medical Marijuana Market Analysis - by Application

  • 8.1 Overview
  • 8.2 North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
  • 8.3 Pain Management
    • 8.3.1 Overview
    • 8.3.2 Pain Management: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Tourette's
    • 8.4.1 Overview
    • 8.4.2 Tourette's: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Alzheimer's Disease
    • 8.5.1 Overview
    • 8.5.2 Alzheimer's Disease: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Migraines
    • 8.6.1 Overview
    • 8.6.2 Migraines: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Depression and Anxiety
    • 8.7.1 Overview
    • 8.7.2 Depression and Anxiety: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Multiple Sclerosis
    • 8.8.1 Overview
    • 8.8.2 Multiple Sclerosis: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.9 Cancer
    • 8.9.1 Overview
    • 8.9.2 Cancer: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Medical Marijuana Market - by Distribution Channel

  • 9.1 Overview
  • 9.2 North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)
  • 9.3 Retail Pharmacy
    • 9.3.1 Overview
    • 9.3.2 Retail Pharmacy: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 E-Commerce
    • 9.4.1 Overview
    • 9.4.2 E-commerce: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Medical Marijuana Market Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 North America Medical Marijuana Market, by Country, 2021 & 2028 (%)
      • 10.1.1.1 US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.2 US: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 US: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.4 US: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.2 Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.2 Canada: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Canada: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.4 Canada: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.3 Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.2 Mexico: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 Mexico: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.4 Mexico: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)

11. North America Medical Marijuana Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the North America Medical Marijuana Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 VIVO Cannabis Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Panaxia Pharmaceutical Industries Ltd.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Phoena Holdings Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Emerald Health Therapeutics Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 MARICANN INC.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Aphria, Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Canopy Growth Corporation
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 CanaQuest Medical Corporation
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 GW Pharmaceuticals
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Organigram Holdings Inc.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms for North America Medical Marijuana Market